[시장보고서]심혈관 중재시술 기기 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 지역별), 부문별 예측(2025-2033년)

심혈관 중재시술 기기 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 지역별), 부문별 예측(2025-2033년)

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices), By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1813809

리서치사 : Grand View Research

발행일 : 2025년 08월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,635,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,087,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,990,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

심혈관 중재시술 기기 시장 요약

전 세계 인터벤션 심장학 장치 시장 규모는 2024년에 105억 7,000만 달러로 평가되었습니다. 2033년에는 197억 5,000만 달러에 달하고, 2025-2033년 7.25%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

시장 성장의 원동력은 심혈관 질환의 유병률 증가, 저침습적 시술에 대한 수요 증가, 약물 용출성 스텐트 및 생체 흡수성 혈관 비계 등의 기술 발전입니다.

고령 인구 증가, 의료비 지출 증가, 신흥 시장에서의 심장 치료 접근성 향상도 시장 확대에 기여하고 있습니다. 제품 혁신과 카테터 기반 중재술에서 AI와 영상의 통합은 수요를 더욱 촉진하고 있습니다. 심혈관 질환의 유병률 증가는 주요 시장 성장 촉진요인입니다. 앉아서 생활하는 생활습관, 식습관의 변화, 비만과 당뇨병 증가율, 관상동맥질환 및 기타 심장질환의 급격한 증가로 인해 전 세계적으로 관상동맥질환 및 기타 심장질환이 급증하고 있습니다. 이러한 질병 부담 증가는 적시에 효과적인 중재에 대한 수요를 증가시키고, 스텐트, 카테터 및 기타 중재 도구의 채택을 촉진하고 있습니다.

2024년 10월, CDC의 보고에 따르면 심장병은 2023년 전체 사망자의 약 1/3에 해당하는 91만 9,000명 이상이 사망한 미국 내 사망 원인 중 1위로 나타났습니다. 34초마다 1명이 심혈관 질환으로 사망하고 있으며, 성인의 약 5%가 관상동맥 질환을 앓고 있습니다. 2020년부터 2021년까지 심장병은 의료비, 약값, 생산성 손실로 4,179억 달러의 경제적 손실을 초래했습니다.

정의와 범위
시장 점유율 분석 : 제품별(2024년/2033년)
부문 대시보드
세계의 심혈관 중재시술 기기 시장 : 제품별(2021-2033년)
관상동맥 스텐트
- 관상동맥 스텐트 시장 추산·예측(2021-2033년)
- DES
- BMS
- BRS
PTCA 풍선 카테터
- PTCA 풍선 카테터 시장 추산·예측(2021-2033년)
- 일반
- 특수
- 약제 코팅
혈관내 이미징 카테터·압력 가이드 와이어
- 혈관내 이미징 카테터 및 압력 가이드 와이어 시장 추산·예측(2021-2033년)
액세서리 디바이스
- 액세서리 디바이스 시장 추산·예측(2021-2033년)
- PTCA 가이드 와이어
- PTCA 가이드 카테터
- 인트로듀서 시스

제5장 심혈관 중재시술 기기 시장 분석 : 지역별(2021-2033년)

시장 점유율 분석 : 지역별(2024년·2034년)
시장 대시보드 : 지역별
시장 현황 : 지역별
심혈관 중재시술 기기 시장 점유율 : 지역별(2024년/2033년)
북미
- 북미의 심혈관 중재시술 기기 시장(2021-2033년)
- 미국
- 캐나다
- 멕시코
유럽
- 유럽의 심혈관 중재시술 기기 시장(2021-2033년)
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제6장 경쟁 구도

주요 시장 진출기업의 최근 동향과 영향 분석
기업 분류
기업 개요
- Abbott
- Medtronic plc
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Koninklijke Philips NV
- Terumo Corporation
- Alvimedica Medical Technologies Inc.
- Teleflex Incorporated
- B. Braun Melsungen AG
- Biosensors International Group, Ltd.
- Meril Life Sciences Pvt. Ltd.
- BIOTRONIK SE &Co. KG.
- ACIST Medical Systems, Inc.
- Asahi Intecc Co., Ltd.
- Cook Medical LLC
- Medinol Ltd.
- Merit Medical Systems, Inc.
- NuMED, Inc.
- OpSens Inc.
- Zeon Medical Inc.

LSH

영문 목차

영문목차

Interventional Cardiology Devices Market Summary

The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market growth is driven by the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, and technological advancements such as drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets also contribute to market expansion. Product innovation and integration of AI and imaging in catheter-based interventions further fuel demand. The rising prevalence of cardiovascular diseases is a primary market driver. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.

In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease incurred a financial toll of USD 417.9 billion in healthcare costs, medications, and lost productivity.

Global Interventional Cardiology Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2021-2033. For this study, Grand View Research, Inc. has segmented the global Interventional cardiology devices market report based on product and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Coronary Stents
- DES
- BMS
- BRS
PTCA Balloon Catheters
Normal
Specialty
Drug-Coated
Intravascular Imaging Catheters and Pressure Guidewires
Accessory Devices
- PTCA Guidewires
- PTCA Guiding Catheters
- Introducer Sheaths
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- Spain
- France
- Sweden
- Denmark
- Norway
Asia Pacific
- China
- India
- Japan
- Thailand
- South Korea
- Australia
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
2.3. Competitive Insights

Chapter 3. Global Interventional Cardiology Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Global Interventional Cardiology Devices: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
3.4. Technology Landscape
3.5. Case Study Analysis

Chapter 4. Global Interventional Cardiology Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Interventional Cardiology Devices Market, by Product, 2021 - 2033
4.5. Coronary Stents
- 4.5.1. Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.2. DES
  - 4.5.2.1. DES market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.3. BMS
  - 4.5.3.1. BMS market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.4. BRS
  - 4.5.4.1. BRS market estimates and forecasts, 2021 - 2033 (USD Million)
4.6. PTCA Balloon Catheters
- 4.6.1. PTCA balloon catheters market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Normal
  - 4.6.2.1. Normal market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Specialty
  - 4.6.3.1. Specialty market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6.4. Drug-Coated
  - 4.6.4.1. Drug-coated market estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Intravascular Imaging Catheters and Pressure Guidewires
- 4.7.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
4.8. Accessory devices
- 4.8.1. Accessory devices market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.8.2. PTCA Guidewires
  - 4.8.2.1. PTCA guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.8.3. PTCA Guiding Catheters
  - 4.8.3.1. PTCA guiding catheters market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.8.4. Introducer Sheaths
  - 4.8.4.1. Introducer sheaths market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Interventional Cardiology Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

5.1. Regional Market Share Analysis, 2024 & 2034
5.2. Regional Market Dashboard
5.3. Regional Market Snapshot
5.4. Interventional Cardiology Devices Market Share by Region, 2024 & 2033:
5.5. North America
- 5.5.1. North America Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.5.2. U.S.
  - 5.5.2.1. Key Country Dynamics
  - 5.5.2.2. Regulatory Scenario
  - 5.5.2.3. Competitive Scenario
  - 5.5.2.4. U.S. Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.5.3. Canada
  - 5.5.3.1. Key Country Dynamics
  - 5.5.3.2. Regulatory Scenario
  - 5.5.3.3. Competitive Scenario
  - 5.5.3.4. Canada Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.5.4. Mexico
  - 5.5.4.1. Key Country Dynamics
  - 5.5.4.2. Regulatory Scenario
  - 5.5.4.3. Competitive Scenario
  - 5.5.4.4. Mexico Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
5.6. Europe
- 5.6.1. Europe Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.2. UK
  - 5.6.2.1. Key Country Dynamics
  - 5.6.2.2. Regulatory Scenario
  - 5.6.2.3. Competitive Scenario
  - 5.6.2.4. UK Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.3. Germany
  - 5.6.3.1. Key Country Dynamics
  - 5.6.3.2. Regulatory Scenario
  - 5.6.3.3. Competitive Scenario
  - 5.6.3.4. Germany Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.4. France
  - 5.6.4.1. Key Country Dynamics
  - 5.6.4.2. Regulatory Scenario
  - 5.6.4.3. Competitive Scenario
  - 5.6.4.4. France Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.5. Italy
  - 5.6.5.1. Key Country Dynamics
  - 5.6.5.2. Regulatory Scenario
  - 5.6.5.3. Competitive Scenario
  - 5.6.5.4. Italy Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.6. Spain
  - 5.6.6.1. Key Country Dynamics
  - 5.6.6.2. Regulatory Scenario
  - 5.6.6.3. Competitive Scenario
  - 5.6.6.4. Spain Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.7. Norway
  - 5.6.7.1. Key Country Dynamics
  - 5.6.7.2. Regulatory Scenario
  - 5.6.7.3. Competitive Scenario
  - 5.6.7.4. Norway Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.8. Sweden
  - 5.6.8.1. Key Country Dynamics
  - 5.6.8.2. Regulatory Scenario
  - 5.6.8.3. Competitive Scenario
  - 5.6.8.4. Sweden Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.6.9. Denmark
  - 5.6.9.1. Key Country Dynamics
  - 5.6.9.2. Regulatory Scenario
  - 5.6.9.3. Competitive Scenario
  - 5.6.9.4. Denmark Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
5.7. Asia Pacific
- 5.7.1. Japan
  - 5.7.1.1. Key Country Dynamics
  - 5.7.1.2. Regulatory Scenario
  - 5.7.1.3. Competitive Scenario
  - 5.7.1.4. Japan Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.7.2. China
  - 5.7.2.1. Key Country Dynamics
  - 5.7.2.2. Regulatory Scenario
  - 5.7.2.3. Competitive Scenario
  - 5.7.2.4. China Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.7.3. India
  - 5.7.3.1. Key Country Dynamics
  - 5.7.3.2. Regulatory Scenario
  - 5.7.3.3. Competitive Scenario
  - 5.7.3.4. India Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.7.4. Australia
  - 5.7.4.1. Key Country Dynamics
  - 5.7.4.2. Regulatory Scenario
  - 5.7.4.3. Competitive Scenario
  - 5.7.4.4. Australia Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.7.5. South Korea
  - 5.7.5.1. Key Country Dynamics
  - 5.7.5.2. Regulatory Scenario
  - 5.7.5.3. Competitive Scenario
  - 5.7.5.4. South Korea Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.7.6. Thailand
  - 5.7.6.1. Key Country Dynamics
  - 5.7.6.2. Regulatory Scenario
  - 5.7.6.3. Competitive Scenario
  - 5.7.6.4. Thailand Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
5.8. Latin America
- 5.8.1. Brazil
  - 5.8.1.1. Key Country Dynamics
  - 5.8.1.2. Regulatory Scenario
  - 5.8.1.3. Competitive Scenario
  - 5.8.1.4. Brazil Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.8.2. Argentina
  - 5.8.2.1. Key Country Dynamics
  - 5.8.2.2. Regulatory Scenario
  - 5.8.2.3. Competitive Scenario
  - 5.8.2.4. Argentina Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
5.9. MEA
- 5.9.1. South Africa
  - 5.9.1.1. Key Country Dynamics
  - 5.9.1.2. Regulatory Scenario
  - 5.9.1.3. Competitive Scenario
  - 5.9.1.4. South Africa Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.9.2. Saudi Arabia
  - 5.9.2.1. Key Country Dynamics
  - 5.9.2.2. Regulatory Scenario
  - 5.9.2.3. Competitive Scenario
  - 5.9.2.4. Saudi Arabia Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.9.3. UAE
  - 5.9.3.1. Key Country Dynamics
  - 5.9.3.2. Regulatory Scenario
  - 5.9.3.3. Competitive Scenario
  - 5.9.3.4. UAE Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
- 5.9.4. Kuwait
  - 5.9.4.1. Key Country Dynamics
  - 5.9.4.2. Regulatory Scenario
  - 5.9.4.3. Competitive Scenario
  - 5.9.4.4. Kuwait Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
- 6.3.1. Abbott
  - 6.3.1.1. Company overview
  - 6.3.1.2. Financial performance
  - 6.3.1.3. Product benchmarking
  - 6.3.1.4. Strategic initiatives
- 6.3.2. Medtronic plc
  - 6.3.2.1. Company overview
  - 6.3.2.2. Financial performance
  - 6.3.2.3. Product benchmarking
  - 6.3.2.4. Strategic initiatives
- 6.3.3. Boston Scientific Corporation
  - 6.3.3.1. Company overview
  - 6.3.3.2. Financial performance
  - 6.3.3.3. Product benchmarking
  - 6.3.3.4. Strategic initiatives
- 6.3.4. Cardinal Health, Inc.
  - 6.3.4.1. Company overview
  - 6.3.4.2. Financial performance
  - 6.3.4.3. Product benchmarking
  - 6.3.4.4. Strategic initiatives
- 6.3.5. Koninklijke Philips N.V.
  - 6.3.5.1. Company overview
  - 6.3.5.2. Financial performance
  - 6.3.5.3. Product benchmarking
  - 6.3.5.4. Strategic initiatives
- 6.3.6. Terumo Corporation
  - 6.3.6.1. Company overview
  - 6.3.6.2. Financial performance
  - 6.3.6.3. Product benchmarking
  - 6.3.6.4. Strategic initiatives
- 6.3.7. Alvimedica Medical Technologies Inc.
  - 6.3.7.1. Company overview
  - 6.3.7.2. Financial performance
  - 6.3.7.3. Product benchmarking
  - 6.3.7.4. Strategic initiatives
- 6.3.8. Teleflex Incorporated
  - 6.3.8.1. Company overview
  - 6.3.8.2. Financial performance
  - 6.3.8.3. Product benchmarking
  - 6.3.8.4. Strategic initiatives
- 6.3.9. B. Braun Melsungen AG
  - 6.3.9.1. Company overview
  - 6.3.9.2. Financial performance
  - 6.3.9.3. Product benchmarking
  - 6.3.9.4. Strategic initiatives
- 6.3.10. Biosensors International Group, Ltd.
  - 6.3.10.1. Company overview
  - 6.3.10.2. Financial performance
  - 6.3.10.3. Product benchmarking
  - 6.3.10.4. Strategic initiatives
- 6.3.11. Meril Life Sciences Pvt. Ltd.
  - 6.3.11.1. Company overview
  - 6.3.11.2. Financial performance
  - 6.3.11.3. Product benchmarking
  - 6.3.11.4. Strategic initiatives
- 6.3.12. BIOTRONIK SE & Co. KG.
  - 6.3.12.1. Company overview
  - 6.3.12.2. Financial performance
  - 6.3.12.3. Product benchmarking
  - 6.3.12.4. Strategic initiatives
- 6.3.13. ACIST Medical Systems, Inc.
  - 6.3.13.1. Company overview
  - 6.3.13.2. Financial performance
  - 6.3.13.3. Product benchmarking
  - 6.3.13.4. Strategic initiatives
- 6.3.14. Asahi Intecc Co., Ltd.
  - 6.3.14.1. Company overview
  - 6.3.14.2. Financial performance
  - 6.3.14.3. Product benchmarking
  - 6.3.14.4. Strategic initiatives
- 6.3.15. Cook Medical LLC
  - 6.3.15.1. Company overview
  - 6.3.15.2. Financial performance
  - 6.3.15.3. Product benchmarking
  - 6.3.15.4. Strategic initiatives
- 6.3.16. Medinol Ltd.
  - 6.3.16.1. Company overview
  - 6.3.16.2. Financial performance
  - 6.3.16.3. Product benchmarking
  - 6.3.16.4. Strategic initiatives
- 6.3.17. Merit Medical Systems, Inc.
  - 6.3.17.1. Company overview
  - 6.3.17.2. Financial performance
  - 6.3.17.3. Product benchmarking
  - 6.3.17.4. Strategic initiatives
- 6.3.18. NuMED, Inc.
  - 6.3.18.1. Company overview
  - 6.3.18.2. Financial performance
  - 6.3.18.3. Product benchmarking
  - 6.3.18.4. Strategic initiatives
- 6.3.19. OpSens Inc.
  - 6.3.19.1. Company overview
  - 6.3.19.2. Financial performance
  - 6.3.19.3. Product benchmarking
  - 6.3.19.4. Strategic initiatives
- 6.3.20. Zeon Medical Inc.
  - 6.3.20.1. Company overview
  - 6.3.20.2. Financial performance
  - 6.3.20.3. Product benchmarking
  - 6.3.20.4. Strategic initiatives